Back
Lexaria Bioscience Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
LEXX
Lexaria Bioscience
Last Price:
2.07
Seasonality Move:
5.11%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Lexaria Bioscience Price Quote
$2.07
-0.02 (-4.17%)
(Updated: November 23, 2024 at 5:42 AM ET)
Lexaria Bioscience Key Stats
Sell
23
Lexaria Bioscience (LEXX)
is a Sell
Day range:
$2.03 - $2.20
52-week range:
$1.20 - $6.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
53.11
P/B ratio:
3.26%
Volume:
115.6K
Avg. volume:
136.1K
1-year change:
58.33%
Market cap:
$33M
Revenue:
$226.2K
EPS:
$-0.44
How Much Does Lexaria Bioscience Make?
-
How Much Are Lexaria Bioscience's Sales Annually?
LEXX Revenues are $226.2K -
How Much Profit Does Lexaria Bioscience's Make A Year?
LEXX net income is -$6.7M
Is Lexaria Bioscience Growing As A Company?
-
What Is Lexaria Bioscience's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Lexaria Bioscience's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Lexaria Bioscience Stock Price Performance
-
Did Lexaria Bioscience Stock Go Up Last Month?
Lexaria Bioscience share price went down by -24.28% last month -
Did LEXX's Share Price Rise Over The Last Year?
LEXX share price rose by 58.33% over the past 1 year
What Is Lexaria Bioscience 52-Week High & Low?
-
What Is Lexaria Bioscience’s 52-Week High Share Price?
Lexaria Bioscience has traded as high as $6.85 over the past 52 weeks -
What Is Lexaria Bioscience’s 52-Week Low Share Price?
Lexaria Bioscience has traded as low as $1.20 over the past 52 weeks
Lexaria Bioscience Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lexaria Bioscience?
-
How Much Debt Does Lexaria Bioscience Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lexaria Bioscience Have?
Cash and short term investments quarterly total is $8.5M -
What Is Lexaria Bioscience’s Book Value Per Share?
Book value per share is 0.64
Is Lexaria Bioscience Cash Flow Positive?
-
What Is LEXX Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.7M -
What Is Lexaria Bioscience’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.2M -
What Is Lexaria Bioscience’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$187.5K
Lexaria Bioscience Return On Invested Capital
-
Is Management Doing A Good Job?
LEXX return on invested capital is -93.31% -
What Is Lexaria Bioscience Return On Assets?
ROA measures how assets are converting to revenues and is -85.62% -
What Is LEXX Return On Equity?
ROE is a measure of profitability and is -93.31%
Lexaria Bioscience Earnings Date & Stock Price
-
What Is Lexaria Bioscience's Stock Price Today?
A single share of LEXX can be purchased today for 2.09 -
What Is Lexaria Bioscience’s Stock Symbol?
Lexaria Bioscience trades on the nasdaq under the ticker symbol: LEXX -
When Is Lexaria Bioscience’s Next Earnings Date?
The next quarterly earnings date for Lexaria Bioscience is scheduled on January 10, 2025 -
When Is LEXX's next ex-dividend date?
Lexaria Bioscience's next ex-dividend date is November 23, 2024 -
How To Buy Lexaria Bioscience Stock?
You can buy Lexaria Bioscience shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lexaria Bioscience Competitors
-
Who Are Lexaria Bioscience's Competitors?
Below is a list of companies who compete with Lexaria Bioscience or are related in some way:
Lexaria Bioscience Dividend Yield
-
What Is LEXX Dividend Yield?
Lexaria Bioscience’s dividend yield currently is 0% -
What Is Lexaria Bioscience’s Payout Ratio?
Lexaria Bioscience’s payout ratio is 0% -
When Did Lexaria Bioscience Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Lexaria Bioscience’s Dividend Per Share?
Lexaria Bioscience pays a dividend of $0.00 per share
Lexaria Bioscience Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 8.1% | -16% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 10.00 |
| Upside from Last Price: | 378.47% |